冻胚移植能否改善卵巢型子宫内膜异位症患者的妊娠结局?
该回顾性队列研究分析了550例20-40岁超声确诊卵巢型子宫内膜异位症且首次接受辅助生殖助孕的女性,比较新鲜胚胎移植(n=170)与冻融胚胎移植(n=380)的妊娠结局。多因素回归校正后,两组在种植率、临床妊娠率、活产率及其他妊娠和新生儿结局上均无显著差异。结论认为冻胚移植未带来额外获益,新鲜胚胎移植仍是可行且可能更省时经济的选择。
要点
- 校正混杂因素后,冻胚与鲜胚移植的活产率无显著差异(校正RR 0.94,95%CI 0.67-1.32)。
- 种植率、临床妊娠率在校正后亦无显著差异,亚组分析结果一致。
- 对卵巢型内异症患者,新鲜胚胎移植仍为可行且可能更经济的选项。
核心结论
- 在卵巢型子宫内膜异位症患者中,冻融胚胎移植相比新鲜胚胎移植未提高活产率或降低妊娠并发症。
- 新鲜胚胎移植在该人群中仍是可行且可能更省时、经济的选择。
研究设计与样本
- 按移植方式分为新鲜胚胎移植组(n=170)和冻融胚胎移植组(n=380),比较基线特征及临床结局。
- 采用多因素回归模型校正潜在混杂因素,并按孕酮浓度、获卵数、子宫腺肌病状态、既往手术或药物治疗、内膜准备方案及移植胚胎阶段进行亚组分析。
主要发现
- 冻融胚胎移植组不孕年限更短、卵巢储备标志物水平更高。
- 未校正分析显示冻融胚胎移植组种植率、临床妊娠率和活产率更高。
- 校正后种植率无显著差异(校正RR 0.89,95%CI 0.67-1.19)。
- 校正后临床妊娠率无显著差异(校正RR 0.90,95%CI 0.68-1.19)。
- 校正后活产率无显著差异(校正RR 0.94,95%CI 0.67-1.32),其他妊娠及新生儿结局亦无显著差异。
临床怎么用
- 对于卵巢型子宫内膜异位症患者,选择冻胚移植不应以改善活产率为主要预期获益。
- 在制定移植策略时,可结合患者时间成本和经济因素考虑新鲜胚胎移植。
局限性
- 本研究为回顾性队列设计,存在选择偏倚可能。
- 冻融胚胎移植组基线特征(不孕年限更短、卵巢储备更高)与新鲜移植组不同,虽经多因素校正仍可能残留混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does frozen embryo transfer improve pregnancy outcomes compared with fresh embryo transfer in women with ovarian endometriosis (OEM) undergoing their first IVF/intracytoplasmic sperm injection cycle? DESIGN: A retrospective cohort study analysed 550 women aged 20-40 years with ultrasound-confirmed OEM who underwent their first assisted reproduction cycle between January 2020 and December 2023. Participants underwent either fresh embryo transfer (n = 170) or frozen embryo transfer (n = 380). Baseline characteristics including ovarian reserve markers, stimulation protocols, and embryo features were compared. Clinical outcomes assessed were clinical pregnancy, live birth, implantation, pregnancy loss, preterm birth, and neonatal complications. Multivariate regression models adjusted for potential confounders. Subgroup analyses considered progesterone concentration, oocyte yield, status of adenomyosis, prior surgery or medical therapy for OEM, endometrial preparation protocols, and stages of transferred embryos. RESULTS: Women in the frozen embryo transfer group had a shorter duration of infertility and higher levels of ovarian reserve markers. Unadjusted analysis showed higher implantation, clinical pregnancy and live birth rates in the frozen embryo transfer group; however, after adjustment, no significant differences were observed in implantation rate [adjusted relative risk (RR) 0.89, 95% CI 0.67-1.19], clinical pregnancy rate (adjusted RR 0.90, 95% CI 0.68-1.19), live birth rate (adjusted RR 0.94, 95% CI 0.67-1.32), and other pregnancy and neonatal outcomes. Subgroup analyses confirmed these findings. CONCLUSIONS: Frozen embryo transfer does not confer a benefit over fresh embryo transfer for improving the live birth rate or reducing pregnancy complications in women with OEM. Fresh embryo transfer remains a viable and potentially more time- and cost-efficient option in this patient population.
引用
- Ma Y, Chen W, Guo S, et al. Does frozen embryo transfer improve pregnancy outcomes in patients with ovarian endometriosis? A retrospective cohort study. Reprod Biomed Online. 2025. PMID: 41916143. doi:10.1016/j.rbmo.2025.105441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。